Gleevec holds potential as first drug to successfully treat neurofibromatosis
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments ...
